Highly rated in
Highly rated in
Check Dr. Forbes D. Porter's experience treating your condition:
About Dr. Forbes D. Porter

Forbes Porter is a Pediatrics specialist and a Medical Genetics expert in Bethesda, Maryland. Porter is highly rated in 30 conditions, according to our data. His top areas of expertise are Smith-Lemli-Opitz Syndrome, Niemann-Pick Disease, Reticulohistiocytoma, and Opitz G BBB Syndrome. He is licensed to treat patients in Maryland.

His clinical research consists of co-authoring 147 peer reviewed articles and participating in 14 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Forbes D. Porter it is best to call his office and ask if your insurance is accepted.

Call to see if your plan is accepted.
10 Center Dr, Bethesda, MD 20892
Background & Education
Medical Genetics
Clinical Genetics in MD
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders
Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation
Cholesterol in Autism Spectrum Disorder (ASD): Characterization and Treatment
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
View 11 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors